News
-
Global CEO slams Aussie pharma for failing to think differently
- Mon Aug 17
Lexicon Pharma CEO Professor Mike Exton says the ANZ industry has been stuck on the same PBS mantra for 20 years and it’s time they moved on.
Read more -
Does Australia need to think outside the PBS box?
- Mon Aug 17
OP-ED: Eli Lilly CEO Dave Ricks says his company is ‘open’ to new funding medicine schemes. Is it time for stakeholders to think differently about access?
Read more -
First‑in‑class therapies come under TGA review
- Mon Aug 17
Newcomers for achondroplasia, cancer among 14 therapies accepted for evaluation. Is the TGA seeing signs of MFN slowdown or rebirth?
Read more -
Date set for Covid vaccines to move to NIP
- Mon Aug 17
Free vaccines for most of the population is coming to an end with only those populations considered at high risk eligible under the NIP.
Read more -
Pharma expert proposes radical access rethink
- Fri Aug 14
Incentives for biotechs to commercialise innovations in Australia along with a private funding model to bridge the gap between TGA registration and the PBS.
Read more -
Greens side with Labor to block IAG report
- Fri Aug 14
A move by Senator Ruston to force the release of the IAG’s final report and roadmap was blocked, raising questions as to what Labor is hiding.
Read more -
AbbVie executives join MA, Pharmac
- Fri Aug 14
Jodie Wilson appointed to key policy role in MA’s senior team as NZ head moves to Pharmac in significant gains for the industry associations.
Read more -
Who’s moved into an advisory role?
- Fri Aug 14
Leading corporate affairs specialists – one from pharma and the other a leading patient group – have joined advisory firms. See who has gone, and where.
Read more